Highlights

  • NUF closed at $2.83 on 9 June 2026, up 0.35% on the day; Bell Potter maintains Buy with a $3.60 price target — implying ~27% upside.
  • H1 FY26 underlying NPAT rose 35% year-on-year to $52 million; underlying EBITDA climbed 18% to $243 million.
  • Net Debt reduced by $135 million on prior corresponding period to $1.23 billion; Leverage target of ~2.0x net debt/EBITDA by end of FY26.

 

Nufarm Limited (ASX:NUF) closed at $2.83 on 9 June 2026, a modest gain of $0.01 or 0.35% on the session. At that price the agrochemical and seeds company trades at a material discount to Bell Potter current Buy recommendation and $3.60 price target, leaving a gap of approximately 27% between the Market Price and the broker assessed Fair Value. For investors weighing whether the stock represents a genuine opportunity or a prolonged de-rating, the gap demands scrutiny.

The share price has been under sustained pressure, reflecting a sector-wide repricing of agricultural input companies amid normalising chemical pricing, tighter Credit conditions, and currency Volatility. Yet the H1 FY26 result, delivered on 27 May 2026, offered the market a set of numbers that, on Face Value, point to a Business executing more effectively than its current Market Capitalisation implies.

H1 FY26 Results: Growth Across Key Metrics

Nufarm first half to 31 March 2026 delivered statutory net profit after tax of $38 million, a 28% improvement on the prior corresponding period. Underlying NPAT reached $52 million, up 35%. Underlying EBITDA of $243 million rose 18% year-on-year. Free Cash Flow improved by $193 million compared to the same period last year — a figure that speaks directly to the operational progress the company has made in managing Working Capital and cost structures.

The Crop Protection division, which remains the primary Earnings engine, generated underlying EBITDA of $223 million, a 3% increase on the prior period, or 6% on a constant currency basis. Europe was the standout, with EBITDA growing 19% — 17% in local currency — as a performance improvement plan reduced operating costs and shifted the product mix toward higher-Margin offerings. North America grew 11% in local currency, with strength in Turf & Ornamental and Canada partially offset by a deliberate pivot toward higher-value products in US Crop Protection.

APAC was the relative weak point, declining 15% on the prior period, primarily due to dry seasonal conditions in Australia and currency headwinds across Asia. The company noted a partial recovery in Australia during March, and highlighted growth in Indonesia as an emerging offset within the Asian portfolio.

Seed Technologies: A Turnaround in Progress

The Seed Technologies segment delivered a marked improvement, with underlying EBITDA of $58 million compared to just $27 million in the prior corresponding period. Hybrid Seeds grew 7% on the prior period, supported by favourable Demand dynamics for edible oils and renewable fuels, South American market expansion, and growth in Australian canola. New varieties of IMI-tolerant canola and sorghum were successfully launched during the half.

The Emerging Platforms segment, which includes the omega-3 canola and carinata programs, reported an EBITDA loss of $4 million — an improvement of $26 million on the prior period. The first regulated trial of omega-3 canola in Argentina and the achievement of deregulation for consumption in Japan represent meaningful regulatory milestones for a program that has historically been a drag on overall profitability. Additionally, Nufarm expansion of its carinata strategic Partnership with bp, extended to 2050, provides milestone-based funding and secured offtake arrangements that underpin the scale-up trajectory.

Deleveraging: The Central Narrative

Net debt stood at $1.23 billion at 31 March 2026, a reduction of $135 million versus the prior corresponding period. Net debt to underlying EBITDA for the twelve months to 31 March 2026 was 3.6 times — a 20% reduction on the comparable prior period ratio. The company is targeting leverage of approximately 2.0 times by the end of FY26, against a FY25 closing ratio of 2.7 times.

The path to that target is supported by an additional $50 million cost savings program announced in April 2026. The program targets asset and portfolio rationalisation, operational efficiencies, and changes to the operating model, with the full run rate expected by the end of FY27. Cash implementation costs are anticipated at approximately $15 million, predominantly in FY27. If the company can execute on this program while sustaining the free cash flow trajectory evidenced in H1, the leverage target is within reach — but it is dependent on normal seasonal and market conditions, which cannot be assumed in the agricultural sector.

FY26 Outlook and Broker Perspective

Management reaffirmed FY26 guidance for both underlying EBITDA and leverage at the time of the H1 result. The company noted positive trading momentum in April and May and flagged ongoing management of cost pressures from active ingredients, freight, and energy arising from Middle East instability. Capital Expenditure is targeted below $200 million, and free cash flow is expected to be positive for the full year.

Conclusion

Nufarm presents as a company in the early stages of a financial and operational reset. The H1 FY26 numbers show measurable progress on earnings, cash generation, and debt reduction. The strategic refresh — with its emphasis on capital efficiency, cost discipline, and portfolio focus — is directionally sensible. However, the Balance Sheet remains elevated, the path to the 2.0x leverage target relies on sustained execution in a cyclical industry, and the Emerging Platforms segment, while improving, has yet to turn consistently profitable. Bell Potter $3.60 Buy rating implies material upside from current levels, but the discount at which NUF trades reflects legitimate questions that the second half of FY26 will need to start answering.